BIOLASE (NASDAQ:BIOL) Coverage Initiated at StockNews.com

Analysts at StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report issued to clients and investors on Monday. The firm set a “sell” rating on the medical technology company’s stock.

BIOLASE Stock Performance

Shares of BIOL opened at $0.01 on Monday. The firm has a fifty day moving average of $0.01 and a 200-day moving average of $0.02. The company has a market cap of $309,014.75, a price-to-earnings ratio of 0.00 and a beta of 0.67. BIOLASE has a 1 year low of $0.02 and a 1 year high of $1.94.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.